Alexander R. Moschen

21.3k total citations · 9 hit papers
122 papers, 15.2k citations indexed

About

Alexander R. Moschen is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Alexander R. Moschen has authored 122 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 29 papers in Molecular Biology and 23 papers in Genetics. Recurrent topics in Alexander R. Moschen's work include Liver Disease Diagnosis and Treatment (31 papers), Inflammatory Bowel Disease (21 papers) and Adipokines, Inflammation, and Metabolic Diseases (20 papers). Alexander R. Moschen is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Inflammatory Bowel Disease (21 papers) and Adipokines, Inflammation, and Metabolic Diseases (20 papers). Alexander R. Moschen collaborates with scholars based in Austria, Germany and United States. Alexander R. Moschen's co-authors include Herbert Tilg, Timon E. Adolph, Arthur Kaser, Romana R. Gerner, Michael Roden, Verena Wieser, Barbara Enrich, Susanne Kaser, Milan Theurl and Tim Raine and has published in prestigious journals such as Circulation, Immunity and Nature reviews. Immunology.

In The Last Decade

Alexander R. Moschen

115 papers receiving 14.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

2006 2.5k citations Herbert Tilg, Alexander R. Moschen profile →
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis

2010 1.9k citations Herbert Tilg, Alexander R. Moschen Hepatology profile →
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties

2007 776 citations Alexander R. Moschen, Arthur Kaser et al. The Journal of Immunology profile →
NAFLD and diabetes mellitus

2016 751 citations Herbert Tilg, Alexander R. Moschen et al. profile →
Inflammatory Mechanisms in the Regulation of Insulin Resistance

2008 604 citations Herbert Tilg, Alexander R. Moschen profile →
Microbiota and diabetes: an evolving relationship

2014 603 citations Herbert Tilg, Alexander R. Moschen Gut profile →
The Intestinal Microbiota in Colorectal Cancer

2018 552 citations Herbert Tilg, Timon E. Adolph et al. profile →
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting

2018 353 citations Alexander R. Moschen, Herbert Tilg et al. profile →
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade

2020 269 citations Herbert Tilg, Timon E. Adolph et al. Hepatology profile →

Peers

Countries citing papers authored by Alexander R. Moschen

Since Specialization

Citations

This map shows the geographic impact of Alexander R. Moschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander R. Moschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander R. Moschen more than expected).

Fields of papers citing papers by Alexander R. Moschen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander R. Moschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander R. Moschen. The network helps show where Alexander R. Moschen may publish in the future.

Co-authorship network of co-authors of Alexander R. Moschen

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander R. Moschen. A scholar is included among the top collaborators of Alexander R. Moschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander R. Moschen. Alexander R. Moschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	S3-Leitlinie Klinische Ernährung bei chronisch-entzündlichen Darmerkrankungen 2025 ·Aktuelle Ernährungsmedizin ·Stephan C. Bischoff, Irina Blumenstein, (unknown), Frank Jochum, Claudia Krieger‐Grübel, Anton J. Kroesen, Alexander R. Moschen, Johann Ockenga, Christiane Schäfer, Tobias Schwerd, Andreas Sturm, Arved Weimann	1
2	Leitfaden Kurzdarmsyndrom 2025 ·Zeitschrift für Gastroenterologie ·(unknown), Christian Datz, (unknown), (unknown), Elisabeth Hütterer, Ludwig Kramer, (unknown), Alexander R. Moschen, Anton Stift, Harald Vogelsang	0
3	Management of major complications after hepatectomy 2025 ·European surgery. Supplement/European surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), Giovanni Scotton, (unknown), (unknown), (unknown), (unknown), (unknown), Pierre Schmit, Alexander R. Moschen, Andreas Shamiyeh, Stefan Stättner	0
4	Sa1765 SYMPTOMATIC REMISSION AND IUS IMPROVEMENTS IN A MULTINATIONAL REAL-WORLD COHORT OF UC PATIENTS TREATED WITH UPADACITINIB - FIRST RESULTS FROM THE IBD-DACH STUDY EUROPE 2024 ·Gastroenterology ·Sebastian Zeißig, Renate Schmelz, Ulf Helwig, Alexander R. Moschen, Thomas Greuter, Imma Fischer, (unknown), Stefan Rath, Torsten Kucharzik, Christian Maaser	1
5	B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19 2023 ·Viruses ·(unknown), (unknown), Andreas Zollner, (unknown), Annika Rössler, (unknown), (unknown), Janine Kimpel, Herbert Tilg, Marlies Antlanger, Elisabeth Schwaiger, Alexander R. Moschen	0
6	The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis 2022 ·Intestinal Research ·Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John Fullarton, Édouard Louis, Fernando Magro, Juan Ricardo Márquez, Alexander R. Moschen, Neeraj Narula, Grażyna Rydzewska, Axel Dignaß, Simon Travis	1
7	Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines 2022 ·npj Vaccines ·Michael Karbiener, Maria R. Farcet, Andreas Zollner, (unknown), Mitsuhiro Mori, Alexander R. Moschen, Thomas R. Kreil	15
8	Short- and Long-Term Effects of a Prebiotic Intervention with Polyphenols Extracted from European Black Elderberry—Sustained Expansion of Akkermansia spp. 2022 ·Journal of Personalized Medicine ·Simon Reider, (unknown), (unknown), (unknown), Nicole Przysiecki, Alexandra Pfister, Andreas Zollner, Herbert Tilg, (unknown), Alexander R. Moschen	17
9	Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis 2021 ·Scandinavian Journal of Gastroenterology ·Axel Dignaß, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John Fullarton, Édouard Louis, Fernando Magro, Juan Ricardo Márquez, Alexander R. Moschen, Neeraj Narula, Grażyna Rydzewska, Simon Travis	5
10	When the genome bluffs: a tandem duplication event during generation of a novel Agmo knockout mouse model fools routine genotyping 2021 ·Cell & Bioscience ·S. Sailer, Stefan Coassin, Katharina Lackner, Caroline Fischer, Eileen McNeill, (unknown), Christian Kremser, Manuel Maglione, Catherine Green, Daniela Moralli, Alexander R. Moschen, Markus A. Keller, Georg Golderer, Gabriele Werner‐Felmayer, Irmgard Tegeder, Keith M. Channon, Benjamin Davies, Ernst R. Werner, Katrin Watschinger	14
11	B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 2021 ·EBioMedicine ·Andreas Zollner, (unknown), Annika Rössler, Maria R. Farcet, (unknown), (unknown), Sophia J. Kiechl, (unknown), (unknown), Herbert Tilg, Robert Koch, Marlies Antlanger, Thomas R. Kreil, Janine Kimpel, Alexander R. Moschen	54
12	Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade breakdown → 2020 ·Hepatology ·Herbert Tilg, Timon E. Adolph, Alexander R. Moschen	269
13	Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 2020 ·Liver International ·Moris Sangineto, Felix Grabherr, Timon E. Adolph, Christoph Grander, Simon Reider, Nikolai Jaschke, Lisa Mayr, Julian Schwärzler, Marcello Dallio, Alexander R. Moschen, Antonio Moschetta, Carlo Sabbà, Herbert Tilg	27
14	Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression 2018 ·Journal of Obesity ·Timon E. Adolph, Felix Grabherr, Lisa Mayr, Christoph Grander, Barbara Enrich, Alexander R. Moschen, Herbert Tilg	15
15	Adipose type I interferon signalling protects against metabolic dysfunction 2016 ·Gut ·Verena Wieser, Timon E. Adolph, Christoph Grander, Felix Grabherr, Barbara Enrich, Patrizia Moser, Alexander R. Moschen, Susanne Kaser, Herbert Tilg	61
16	Microbiota and diabetes: an evolving relationship breakdown → 2014 ·Gut ·Herbert Tilg, Alexander R. Moschen	603
17	Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression? 2009 ·European Cytokine Network ·Herbert Tilg, Alexander R. Moschen, Arthur Kaser	13
18	Gut, inflammation and osteoporosis: basic and clinical concepts 2008 ·Gut ·Herbert Tilg, Alexander R. Moschen, Arthur Kaser, Amos Pines, Iris Dotan	237
19	Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction 2007 ·Gastroenterology ·Michelle M. Richardson, Julie R. Jonsson, Elizabeth E. Powell, Elizabeth M. Brunt, Brent A. Neuschwander‐Tetri, Prithi S. Bhathal, John B. Dixon, Martin Weltman, Herbert Tilg, Alexander R. Moschen, David M. Purdie, Anthony J. Demetris, Andrew D. Clouston	359
20	Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties breakdown → 2007 ·The Journal of Immunology ·Alexander R. Moschen, Arthur Kaser, Barbara Enrich, Birgit Mosheimer, Milan Theurl, Harald Niederegger, Herbert Tilg	776

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact